| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,623 |
14,424 |
$5.43M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
16,319 |
1,619 |
$5.38M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,289 |
14,961 |
$4.60M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
6,778 |
6,375 |
$3.49M |
| 90837 |
Psychotherapy, 53 minutes with patient |
27,096 |
10,746 |
$2.29M |
| G0378 |
Hospital observation service, per hour |
1,076 |
909 |
$898K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,221 |
3,914 |
$613K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,754 |
7,914 |
$286K |
| 95806 |
|
184 |
179 |
$222K |
| 90791 |
Psychiatric diagnostic evaluation |
2,456 |
2,082 |
$211K |
| 90834 |
Psychotherapy, 45 minutes with patient |
4,312 |
2,869 |
$209K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,300 |
2,215 |
$187K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
351 |
341 |
$179K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,441 |
6,743 |
$172K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,345 |
6,437 |
$169K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,956 |
2,514 |
$158K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,577 |
4,914 |
$109K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,299 |
2,193 |
$102K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,024 |
999 |
$101K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,662 |
2,563 |
$101K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,581 |
3,420 |
$95K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,833 |
1,255 |
$90K |
| 93975 |
|
1,249 |
1,205 |
$81K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,729 |
1,661 |
$79K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,950 |
733 |
$75K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,948 |
2,846 |
$74K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,267 |
1,167 |
$68K |
| 71046 |
Radiologic examination, chest; 2 views |
4,513 |
4,358 |
$68K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,248 |
1,186 |
$60K |
| 87631 |
|
1,599 |
1,514 |
$57K |
| 71045 |
Radiologic examination, chest; single view |
4,876 |
4,614 |
$57K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,895 |
1,477 |
$56K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,052 |
2,822 |
$53K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,057 |
2,929 |
$50K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,345 |
2,884 |
$49K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
792 |
769 |
$46K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,245 |
440 |
$44K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
795 |
735 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,206 |
1,177 |
$37K |
| 76801 |
|
902 |
834 |
$37K |
| OP279 |
|
1,093 |
1,059 |
$36K |
| 80053 |
Comprehensive metabolic panel |
9,558 |
8,733 |
$35K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,715 |
1,427 |
$35K |
| 94760 |
|
16,721 |
14,468 |
$35K |
| 76830 |
Ultrasound, transvaginal |
691 |
676 |
$34K |
| 36000 |
|
2,812 |
2,692 |
$31K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,417 |
8,511 |
$31K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,446 |
16,030 |
$28K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
346 |
325 |
$26K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
982 |
943 |
$26K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,546 |
513 |
$25K |
| OP259 |
|
16,606 |
12,950 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
20,118 |
16,648 |
$22K |
| 93041 |
|
2,359 |
2,214 |
$22K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,475 |
1,414 |
$21K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
469 |
423 |
$20K |
| 84484 |
|
3,975 |
3,483 |
$19K |
| 73630 |
|
1,361 |
1,306 |
$18K |
| 87581 |
|
1,466 |
1,423 |
$18K |
| 87486 |
|
1,467 |
1,423 |
$18K |
| 96112 |
|
102 |
95 |
$18K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
805 |
768 |
$17K |
| 73130 |
|
1,147 |
1,103 |
$16K |
| 73564 |
|
1,054 |
1,002 |
$16K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
14 |
14 |
$15K |
| 96113 |
|
101 |
94 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,479 |
1,417 |
$15K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
465 |
448 |
$14K |
| 80320 |
|
2,948 |
2,576 |
$13K |
| 73610 |
|
1,009 |
976 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
556 |
534 |
$12K |
| 86901 |
|
604 |
578 |
$12K |
| 96376 |
|
1,140 |
947 |
$12K |
| 93971 |
|
202 |
196 |
$11K |
| 73030 |
|
773 |
746 |
$11K |
| 80076 |
|
3,975 |
3,726 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,142 |
1,090 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,073 |
1,047 |
$9K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$8K |
| 83690 |
|
4,958 |
4,622 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,512 |
2,412 |
$8K |
| 80329 |
|
1,002 |
930 |
$8K |
| 87081 |
|
2,301 |
2,237 |
$7K |
| 84703 |
|
5,886 |
5,499 |
$7K |
| 85610 |
|
5,961 |
5,583 |
$7K |
| 90715 |
|
562 |
551 |
$7K |
| 81003 |
|
11,485 |
10,640 |
$7K |
| 73110 |
|
382 |
366 |
$6K |
| G2251 |
Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion |
96 |
87 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,395 |
1,363 |
$6K |
| J3490 |
Unclassified drugs |
4,589 |
3,487 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,524 |
2,417 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
476 |
446 |
$6K |
| 83880 |
|
471 |
447 |
$5K |
| 90785 |
|
129 |
106 |
$5K |
| 86900 |
|
593 |
567 |
$5K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
103 |
30 |
$5K |
| 85730 |
|
3,812 |
3,630 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
83 |
74 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,857 |
7,314 |
$5K |
| 71250 |
|
162 |
156 |
$5K |
| 84702 |
|
1,078 |
948 |
$5K |
| 87040 |
|
706 |
671 |
$4K |
| 93017 |
|
12 |
12 |
$4K |
| 97010 |
|
2,166 |
672 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
156 |
142 |
$4K |
| 81025 |
|
3,437 |
3,203 |
$4K |
| 83605 |
|
784 |
736 |
$4K |
| 74022 |
|
244 |
234 |
$4K |
| 85379 |
|
1,915 |
1,837 |
$3K |
| 83735 |
|
1,967 |
1,717 |
$3K |
| 81001 |
|
6,022 |
5,668 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
202 |
124 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,932 |
4,415 |
$3K |
| 80306 |
|
160 |
154 |
$3K |
| 87147 |
|
2,364 |
2,301 |
$3K |
| 82962 |
|
1,791 |
1,370 |
$3K |
| 82150 |
|
1,588 |
1,519 |
$2K |
| 72131 |
|
129 |
126 |
$2K |
| OP250 |
|
1,071 |
915 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
82 |
74 |
$2K |
| 97161 |
|
49 |
45 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,181 |
3,662 |
$2K |
| OP229 |
|
31 |
29 |
$2K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
32 |
27 |
$2K |
| 70486 |
|
58 |
58 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
664 |
629 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,876 |
1,596 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
685 |
589 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,209 |
989 |
$1K |
| 72100 |
|
70 |
67 |
$1K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13 |
13 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
957 |
817 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,688 |
1,546 |
$1K |
| 72110 |
|
55 |
51 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
19 |
13 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
75 |
60 |
$1K |
| 87186 |
|
228 |
219 |
$856.60 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,017 |
862 |
$848.22 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
1,175 |
1,150 |
$831.80 |
| 73502 |
|
43 |
41 |
$827.25 |
| 86850 |
|
71 |
67 |
$725.20 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$694.43 |
| 76536 |
|
12 |
12 |
$690.61 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,463 |
989 |
$671.77 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,355 |
1,304 |
$651.36 |
| 12001 |
|
12 |
12 |
$641.72 |
| 82550 |
|
303 |
277 |
$552.37 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,259 |
1,104 |
$510.19 |
| 85652 |
|
672 |
651 |
$399.60 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
911 |
849 |
$374.38 |
| 87077 |
|
144 |
138 |
$367.58 |
| 86140 |
|
204 |
194 |
$276.86 |
| 80061 |
Lipid panel |
32 |
31 |
$252.61 |
| 87807 |
|
73 |
73 |
$246.64 |
| 73080 |
|
15 |
14 |
$239.09 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
149 |
136 |
$238.62 |
| 85027 |
|
132 |
128 |
$225.93 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
816 |
724 |
$223.42 |
| 85055 |
|
15 |
14 |
$216.08 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
848 |
787 |
$209.20 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
76 |
70 |
$203.77 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
242 |
208 |
$141.64 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
66 |
59 |
$123.24 |
| 85008 |
|
409 |
382 |
$82.26 |
| 87071 |
|
25 |
25 |
$79.73 |
| 86308 |
|
54 |
50 |
$58.50 |
| OP637 |
|
435 |
314 |
$36.59 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
19 |
12 |
$32.94 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
105 |
94 |
$32.63 |
| 80178 |
|
12 |
12 |
$31.95 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
78 |
68 |
$26.92 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
15 |
14 |
$19.76 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
15 |
14 |
$3.00 |
| A9270 |
Non-covered item or service |
15 |
12 |
$0.00 |